Reduction of opioid withdrawal symptoms and opioid-induced hyperalgesia by subcutaneous sumatriptan reveals central neuromodulation. - Pistolesi A; De Cesaris F; Buonvicino D; Chiarugi A (The journal of pain, 2025)